Skip to content
← Survival collections

POPULATION SURVIVAL

HR-/HER2+ Breast Cancer (Female only)

Published source values

Female · All Ages · All Stages · All Races / Ethnicities

Source
SEER
Table
Recent Trends
Data submission
November 2025 submission
Application release
Updated
June 22, 2026
Retrieved
Diagnosis years
2010 to 2022
5-year Relative Survival by diagnosis year for HR-/HER2+ Breast Cancer (Female only). Source table: SEER Recent Trends.
Diagnosis yearRelative survival (%)Lower CIUpper CIStandard errorModeled (%)Source count
201083.62903881.95720285.1602690.81635284.0167042884
201183.87741882.25651685.3636830.79192384.3935083018
201284.23607482.64221685.6964880.77842184.7622563124
201386.67399585.16646288.0392410.73189985.1230783197
201485.24939683.78153086.5952330.71709785.4761063449
201585.84538284.42824087.1435440.69199485.8214723716
201685.02889383.54333286.3914740.72588586.1593053495
201786.71618485.27289488.0281130.70201686.4897373564
201888.03803486.55512089.3675660.71628886.8128983328
2019Not publishedNot publishedNot publishedNot published87.128916Not published
2020Not publishedNot publishedNot publishedNot published87.437921Not published
2021Not publishedNot publishedNot publishedNot published87.740039Not published
2022Not publishedNot publishedNot publishedNot published88.035399Not published

Open the SEER source

Filters stay in your browser. Some combinations have no estimate.

SEER · SOURCE POPULATIONS

Recent survival trends

Compare diagnosis years, not years since diagnosis. These estimates describe different diagnosis eras—not one person’s changing outlook.

Loading the exact source populations…

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Relative survival compares cancer populations with the general population. It is not the percentage of people alive, a treatment effect, or a personal forecast. Diagnosis-period dates were not labeled in the recovered package; see the source notes below.